Anti-?ubulin antibodies have no diagnostic value in patients with chronic inflammatory demyelinating polyneuropathy
Authors:
- 1 January 1995
- journal article
- Published by Springer Nature in Journal of Neurology
- Vol. 242 (9) , 599-603
Abstract
High-titre anti-β-tubulin antibodies were recently reported to occur in over 50% of sera from patients with chronic inflammatory demyelinating polyneuropathy (CIDP). It was concluded that these antibodies may help to distinguish CIDP from other neuropathies and that they are diagnostically useful. To verify these findings, we studied sera of 43 CIDP patients, only 3 of whom had anti-β-tubulin antibodies. The differences between the results obtained cannot fully be explained by differences between patients or antigens but may be explained by the use of different techniques (Western blot versus ELISA). We used Western blot, which is less sensitive but far more specific, to detect these antibodies. The findings of our study did not confirm the high frequency of selective high-titre anti-β-tubulin antibodies in CIDP patients. Therefore we conclude that binding to β-tubulin by Western blot cannot serve as a marker of CIDP.Keywords
This publication has 18 references indexed in Scilit:
- Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg)Journal of Neuroimmunology, 1994
- Immune-mediated neuropathiesCurrent Opinion in Neurology, 1993
- Spontaneous Recovery from the Guillain-Barré Syndrome Is Associated with Anti-idiotypic Antibodies Recognizing a Cross-Reactive Idiotype on Anti-neuroblastoma Cell Line AntibodiesClinical Immunology and Immunopathology, 1993
- Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathyJournal of the Neurological Sciences, 1992
- Clinical correlations of Anti‐Gm1 antibodies in amyotrophic lateral sclerosis and neuropathiesMuscle & Nerve, 1991
- Analysis of β‐tubulin sequences reveals highly conserved, coordinated amino acid substitutionsFEBS Letters, 1990
- Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodiesAnnals of Neurology, 1990
- Regulation of Autoantibodies in Inflammatory Demyelinating Polyneuropathy: Spontaneous and TherapeuticImmunological Reviews, 1989
- Anti‐neuroblastoma cell line antibodies in inflammatory demyelinating polyneuropathyNeurology, 1988
- Plasma Exchange in Chronic Inflammatory Demyelinating PolyradiculoneuropathyNew England Journal of Medicine, 1986